Experimental exposure to 1,1,1-trifluoroethane (HFC-143a): Uptake, disposition and acute effects in male volunteers

Toxicology Letters

Volumn 172, Issue 3, 2007, Pages 120-130

  Gunnare, Sara ^a,b   Ernstgård, Lena ^a   Sjögren, Bengt ^a   Johanson, Gunnar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

Author keywords

Blood:air partition coefficient; HFC 143a; Human; Hydrofluorocarbon; Inflammatory marker; Physiologically based toxicokinetic model

Indexed keywords

1,1,1 TRIFLUOROETHANE; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; FLUORINATED HYDROCARBON; SERUM AMYLOID A; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AIR SAMPLING; ARTICLE; BICYCLE ERGOMETER; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; EXERCISE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MALE; NORMAL HUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SYMPTOMATOLOGY; TOXICOKINETICS; URINALYSIS; URINARY EXCRETION; VISUAL ANALOG SCALE;

ADMINISTRATION, INHALATION; ADULT; ELECTROCARDIOGRAPHY; EXERCISE; FIBRINOGEN; HUMANS; HYDROCARBONS, FLUORINATED; LUNG; MALE; MODELS, BIOLOGICAL;

EID: 34547547967     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.05.010     Document Type: Article

References (28)

1. Ahlborg, B., Edling, C., Hagberg, M., Hagberg, S., 1999. Kylmontörers hälsa och arbetsmiljö 1998-En undersökning med frågeformulär inriktad på köldmedier och oljor. Report no. 70 (in Swedish), Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
2. Beliveau M., Tardif R., and Krishnan K. Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol. Appl. Pharmacol. 189 (2003) 221-232
3. Bremner W.F., Sothern R.B., Kanabrocki E.L., Ryan M., McCormick J.B., Dawson S., Connors E.S., Rothschild R., Third J.L., Vahed S., Nemchausky B.M., Shirazi P., and Olwin J.H. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am. Heart J. 139 (2000) 164-173
4. Brock W.J., Trochimowicz H.J., Farr C.H., Millischer R.J., and Rusch G.M. Acute, subchronic, and developmental toxicity and genotoxicity of 1,1,1-trifluoroethane (HFC-143a). Fundam. Appl. Toxicol. 31 (1996) 200-209
5. Calm J.M., and Hourahan G.C. Refrigeration data summary. Engineered Systems 18 (2001) 74-88
6. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
7. Dekant W. Toxicology of chlorofluorocarbon replacements. Environ. Health Perspect. 104 Suppl. 1 (1996) 75-83
8. Eger II E.I., Liu J., Koblin D.D., Laster M.J., Taheri S., Halsey M.J., Ionescu P., Chortkoff B.S., and Hudlicky T. Molecular properties of the "ideal" inhaled anesthetic: studies of fluorinated methanes, ethanes, propanes, and butanes. Anesth. Analg. 79 (1994) 245-251
9. El-Sayed M.S., Sale C., Jones P.G., and Chester M. Blood hemostasis in exercise and training. Med. Sci. Sports Exerc. 32 (2000) 918-925
10. Emmen H.H., Hoogendijk E.M., Klopping-Ketelaars W.A., Muijser H., Duistermaat E., Ravensberg J.C., Alexander D.J., Borkhataria D., Rusch G.M., and Schmit B. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3,3- heptafluoropropane) following whole-body exposure. Regul. Toxicol. Pharmacol. 32 (2000) 22-35
11. Ernstgård L., Sjögren B., Warholm M., and Johanson G. Sex differences in the toxicokinetics of inhaled solvent vapors in humans. 2. 2-Propanol. Toxicol. Appl. Pharmacol. 193 (2003) 158-167
12. Gjølstad M., Ellingsen D.G., Espeland O., Nordby K.C., Evenseth H., Thorud S., Skaugset N.P., and Thomassen Y. Occupational exposure to fluorinated hydrocarbons during refrigeration repair work. J. Environ. Monit. 5 (2003) 236-240
13. Gunnare S., Ernstgård L., Sjögren B., and Johanson G. Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure. Toxicol. Lett. 167 (2006) 54-65
14. Hagberg, S., Lillienberg, L., 1999. Kylmontörer. Yrkeshygienisk bedömning av kylmontörers exponering för kemiska produkter. En litteraturstudie. Report no. 71 (in Swedish), Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
15. Kawano T., Trochimowicz H.J., Malinverno G., and Rusch G.M. Toxicological evaluation of 1,1,1,2,2-pentafluoroethane (HFC-125). Fundam. Appl. Toxicol. 28 (1995) 223-231
16. Kjellberg A., Landström U., Löfstedt P., Wide P., and Åkerlund E. Estimation of noise and annoyance in working environments. Arbete och Hälsa 1988:30 (in Swedish) (1988), National Institute of Occupational Health, Solna, Sweden
17. Lillienberg, L., Ahlborg, B., Ahlborg jr, G., Anundi, H., Blixt, P., Dahlman-Höglund, A., Edling, C., Godenius, P., Hagberg, M., Karlberg, C., Pfeifer, A., Torén, K., Uddenfeldt, M., 2002. Exponering för köldmedier och oljor och risk för influensa-liknande symptom, ledbesvär och luftvägssjukdom-en fall kontroll studie. Report no. 97 (in Swedish), Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
18. Loupos D., Tsalis G., Alexiou S., and Gounaris I. Changes of plasma fibrinogen and fibrinolysis in response to competition stress in swimming coaches. J. Sports Med. Phys. Fitness 45 (2005) 424-427
19. Malmberg P., Hedenström H., and Fridriksson H.V. Reference values for gas exchange during exercise in healthy nonsmoking and smoking men. Bull. Eur. Physiopathol. Respir. 23 (1987) 131-138
20. Monte S.Y., Ismail I., Mallett D.N., Matthews C., and Tanner R.J. The minimal metabolism of inhaled 1,1,1,2-tetrafluoroethane to trifluoroacetic acid in man as determined by high sensitivity 19F nuclear magnetic resonance spectroscopy of urine samples. J. Pharm. Biomed. Anal. 12 (1994) 1489-1493
21. Montelius J. (Ed.), 1999. Scientific Basis for Swedish Occupational Standards. XX. Consensus Report for 1,1,1-trifluoroethane and 1,1,1,2,2-pentafluoroethane. Arbete och Hälsa (1999) 26, 48-53. National Institute for Working Life, Solna, Sweden.
22. Nihlén A., and Johanson G. Physiologically based toxicokinetic modeling of inhaled ethyl tertiary-butyl ether in humans. Toxicol. Sci. 51 (1999) 184-194
23. Pike V.W., Aigbirhio F.I., Freemantle C.A., Page B.C., Rhodes C.G., Waters S.L., Jones T., Olsson P., Ventresca G.P., Tanner R.J., Hayes M., and Hughes J.M. Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting. Drug Metab. Dispos. 23 (1995) 832-839
24. Sundblad B.M., Larsson B.M., Acevedo F., Ernstgård L., Johanson G., Larsson K., and Palmberg L. Acute respiratory effects of exposure to ammonia on healthy persons. Scand J. Work Environ. Health 30 (2004) 313-321
25. SWEA. Occupational Exposure Limit Values and Measures Against Air Contaminants. Ordinance AFS 2005:17 (2005), Swedish Work Environment Authority, Solna, Sweden
26. Trochimowicz H.J. Industrial research on alternative fluorocarbons. Toxicol. Lett. 68 (1993) 25-30
27. Ventresca G.P. Clinical pharmacology of HFA134a. J. Aerosol. Med. 8 Suppl. 1 (1995) S35-S39
28. Vinegar, A., Jepson, G.W., Cook, R.S., McCafferty, J.D., Caracci, M.C. 1997. Human Inhalation of Halon 1301, HFC-134a and HFC-227ea for Collection of Pharmacokinetic Data. Wright-Patterson Air Force Base, Dayton, OH, United States.